Skip to main content
. 2020 Feb 18;86(6):1089–1099. doi: 10.1111/bcp.14217

Table 2.

Statin use and pharmacokinetics data

Subjects Dose (mg d–1) Bioavailability Half‐life (h) Renal excretion (%) Solubility
Atorvastatina 4 20–80 12% 14 5 Lipophilic
Pitavastatina 2 2–2 80% 11 NA Lipophilic
Simvastatina 2 10–20 5% 2 13 Lipophilic
Rosuvastatina 2 10–20 20% 19 10 Hydrophilic

Schachter64